Healthcare provider profile · identity verified

Benjamin Dellaria

Family Practice · NEW LONDON, WI · NPI 1942695713

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	739	189
Amlodipine Besylate	Amlodipine Besylate	382	108
Lisinopril	Lisinopril	282	74
Furosemide	Furosemide	265	67
Losartan Potassium	Losartan Potassium	257	71
Omeprazole	Omeprazole	222	59
Metoprolol Tartrate	Metoprolol Tartrate	220	51
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	201	58
Spironolactone	Spironolactone	196	55
Levothyroxine Sodium	Levothyroxine Sodium	193	49
Metformin Hcl	Metformin Hcl	183	51
Metoprolol Succinate	Metoprolol Succinate	177	49
Eliquis	Apixaban	176	47
Hydrochlorothiazide	Hydrochlorothiazide	173	53
Simvastatin	Simvastatin	141	39
Potassium Chloride	Potassium Chloride	139	40
Pantoprazole Sodium	Pantoprazole Sodium	134	35
Tamsulosin Hcl	Tamsulosin Hcl	133	42
Gabapentin	Gabapentin	120	34
Mirtazapine	Mirtazapine	113	23
Citalopram Hbr	Citalopram Hydrobromide	109	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	105	31
Glipizide	Glipizide	94	25
Albuterol Sulfate Hfa	Albuterol Sulfate	92	35
Rosuvastatin Calcium	Rosuvastatin Calcium	86	29
Trazodone Hcl	Trazodone Hcl	82	22
Jardiance	Empagliflozin	80	19
Atenolol	Atenolol	78	21
Metformin Hcl Er	Metformin Hcl	77	22
Trulicity	Dulaglutide	75	14
Clopidogrel	Clopidogrel Bisulfate	69	14
Allopurinol	Allopurinol	67	17
Escitalopram Oxalate	Escitalopram Oxalate	61	16
Alendronate Sodium	Alendronate Sodium	60	18
Prednisone	Prednisone	59	45
Ezetimibe	Ezetimibe	58	13
Tramadol Hcl	Tramadol Hcl	58	22
Bumetanide	Bumetanide	56	13
Pravastatin Sodium	Pravastatin Sodium	55	15
Carvedilol	Carvedilol	54	16
Doxazosin Mesylate	Doxazosin Mesylate	54	12
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Lorazepam	Lorazepam	54	22
Sertraline Hcl	Sertraline Hcl	49	16
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Buspirone Hcl	Buspirone Hcl	47	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	12
Warfarin Sodium	Warfarin Sodium	47	suppressed
Lovastatin	Lovastatin	46	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	11
Synthroid	Levothyroxine Sodium	43	13
Tizanidine Hcl	Tizanidine Hcl	43	13
Symbicort	Budesonide/Formoterol Fumarate	41	11
Pregabalin	Pregabalin	40	suppressed
Doxepin Hcl	Doxepin Hcl	38	17
Glipizide Er	Glipizide	38	suppressed
Methimazole	Methimazole	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Finasteride	Finasteride	30	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Clobetasol Propionate	Clobetasol Propionate	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	14
Cefdinir	Cefdinir	25	22
Meloxicam	Meloxicam	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Famotidine	Famotidine	24	suppressed
Baclofen	Baclofen	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Ozempic	Semaglutide	21	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Cephalexin	Cephalexin	17	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Nystatin	Nystatin	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Colchicine	Colchicine	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Primidone	Primidone	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error